LV10684B - Controlled release preparation containing a salt of morphine - Google Patents
Controlled release preparation containing a salt of morphineInfo
- Publication number
- LV10684B LV10684B LVP-94-228A LV940228A LV10684B LV 10684 B LV10684 B LV 10684B LV 940228 A LV940228 A LV 940228A LV 10684 B LV10684 B LV 10684B
- Authority
- LV
- Latvia
- Prior art keywords
- morphine
- salt
- controlled release
- preparations
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9301057A SE9301057L (sv) | 1993-03-30 | 1993-03-30 | Beredning med kontrollerad frisättning |
PCT/SE1994/000264 WO1994022431A1 (fr) | 1993-03-30 | 1994-03-24 | Preparation a liberation controlee contenant un sel de morphine |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10684A LV10684A (lv) | 1995-06-20 |
LV10684B true LV10684B (en) | 1996-02-20 |
Family
ID=20389415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-94-228A LV10684B (en) | 1993-03-30 | 1994-11-30 | Controlled release preparation containing a salt of morphine |
Country Status (25)
Country | Link |
---|---|
US (1) | US5614218A (fr) |
EP (1) | EP0642335B2 (fr) |
JP (1) | JP4107678B2 (fr) |
KR (1) | KR100316206B1 (fr) |
CN (1) | CN1104891C (fr) |
AT (1) | ATE189771T1 (fr) |
AU (1) | AU680891C (fr) |
CA (1) | CA2135639C (fr) |
CZ (1) | CZ284924B6 (fr) |
DE (1) | DE69423028T3 (fr) |
DK (1) | DK0642335T4 (fr) |
EE (1) | EE03147B1 (fr) |
ES (1) | ES2144516T5 (fr) |
FI (1) | FI113743B (fr) |
GR (1) | GR3033325T3 (fr) |
HU (1) | HU227344B1 (fr) |
LV (1) | LV10684B (fr) |
NO (1) | NO310015B1 (fr) |
NZ (1) | NZ263632A (fr) |
PL (1) | PL175326B1 (fr) |
PT (1) | PT642335E (fr) |
RU (1) | RU2136283C1 (fr) |
SE (1) | SE9301057L (fr) |
SK (1) | SK280362B6 (fr) |
WO (1) | WO1994022431A1 (fr) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
AU735113C (en) * | 1991-12-24 | 2007-06-14 | Mundipharma Medical Gmbh | Opioid formulations for treating pain |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US20080075781A1 (en) * | 1992-11-25 | 2008-03-27 | Purdue Pharma Lp | Controlled release oxycodone compositions |
IL109460A (en) * | 1993-05-10 | 1998-03-10 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
US20070275062A1 (en) * | 1993-06-18 | 2007-11-29 | Benjamin Oshlack | Controlled release oxycodone compositions |
IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
IL109944A (en) † | 1993-07-01 | 1998-12-06 | Euro Celtique Sa | Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5891471A (en) * | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
US20020006438A1 (en) * | 1998-09-25 | 2002-01-17 | Benjamin Oshlack | Sustained release hydromorphone formulations exhibiting bimodal characteristics |
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
DE19607395C2 (de) * | 1996-02-28 | 2002-11-21 | Lohmann Therapie Syst Lts | Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate |
US6245351B1 (en) | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
FR2794646B1 (fr) | 1999-06-09 | 2001-09-21 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
KR20020059653A (ko) | 1999-10-29 | 2002-07-13 | 그린 마틴, 브라이언 쥐 테슬리 | 서방성 하이드로코돈 제형 |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
JP2004512354A (ja) | 2000-10-30 | 2004-04-22 | ユーロ−セルティーク,エス.エイ. | ヒドロコドン放出制御製剤 |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
AU4061702A (en) * | 2001-05-15 | 2003-04-03 | Mcneil-Ppc, Inc. | Dip coating compositions containing starch or dextrin |
US20030070584A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US20030072731A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing starch or dextrin |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
US8309118B2 (en) * | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
AU2003225837B2 (en) * | 2002-03-15 | 2008-11-06 | Forest Laboratories Holdings Limited | NE and 5-HT reuptake inhibitors for treating visceral pain syndromes |
US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US7815934B2 (en) * | 2002-09-20 | 2010-10-19 | Alpharma Pharmaceuticals, Llc | Sequestering subunit and related compositions and methods |
AU2003272601B2 (en) * | 2002-09-20 | 2009-05-07 | Alpharma Pharmaceuticals, Llc | Sustained-release opioid formulations and methods of use |
EP1546120A4 (fr) * | 2002-10-04 | 2006-11-22 | Pharmacia Corp | Compositions pharmaceutiques pour le traitement de la maladie de parkinson |
US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
WO2004067039A1 (fr) * | 2003-01-28 | 2004-08-12 | Collegium Pharmaceutical, Inc. | Compositions multiparticulaires de milnacipran destinees a etre administrees par voie orale |
US8877241B2 (en) | 2003-03-26 | 2014-11-04 | Egalet Ltd. | Morphine controlled release system |
TWI347201B (en) * | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
ES2336913T3 (es) * | 2003-08-08 | 2010-04-19 | Biovail Laboratories International Srl | Comprimido de liberacion modificada de hidrocloruro de bupropion. |
EP1810678A1 (fr) | 2006-01-19 | 2007-07-25 | Holger Lars Hermann | Utilisation de morphine et naloxone pour la substitution de médicaments |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US20080069871A1 (en) * | 2006-07-21 | 2008-03-20 | Vaughn Jason M | Hydrophobic abuse deterrent delivery system |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
EP2155167A2 (fr) | 2007-06-04 | 2010-02-24 | Egalet A/S | Compositions pharmaceutiques à libération contrôlée pour un effet prolongé |
JP5965583B2 (ja) | 2007-08-13 | 2016-08-10 | インスピリオン デリバリー テクノロジーズ エルエルシー | 乱用抵抗性医薬組成物、その使用方法および作製方法 |
GB2462022B (en) * | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
DK3045043T3 (da) | 2009-02-26 | 2020-08-03 | Relmada Therapeutics Inc | Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse |
EP2445487A2 (fr) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Formulations à libération contrôlée |
CA2798702A1 (fr) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Formes dosifiees orales a liberation prolongee contenant du metoprolol resistantes aux alcools |
MX2013000024A (es) | 2010-07-06 | 2013-02-01 | Gruenenthal Gmbh | Nuevas formas de dosificacion gastrorretentivas. |
EA201590165A1 (ru) | 2012-07-06 | 2015-08-31 | Эгалет Лтд. | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения |
CA2907428A1 (fr) | 2013-03-15 | 2014-09-18 | Inspirion Delivery Technologies, Llc | Compositions anti-abus et methodes d'utilisation |
WO2015023675A2 (fr) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération immédiate |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
AU2015290098B2 (en) | 2014-07-17 | 2018-11-01 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
EP3209282A4 (fr) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Forme galénique anti-abus de remplissage de liquide à libération prolongée |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
CA2007181C (fr) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Compose pharmaceutique a liberation continue |
SE8902699D0 (sv) * | 1989-08-09 | 1989-08-09 | Lejus Medical Ab | Diltiazem containing pharmaceutical compositios |
DE4105480A1 (de) * | 1991-02-21 | 1992-08-27 | Boehringer Mannheim Gmbh | Verbesserte aktivierung von rekombinanten proteinen |
US5273760A (en) † | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5478577A (en) † | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
-
1993
- 1993-03-30 SE SE9301057A patent/SE9301057L/xx not_active Application Discontinuation
-
1994
- 1994-03-16 US US08/213,518 patent/US5614218A/en not_active Expired - Lifetime
- 1994-03-24 DK DK94912116T patent/DK0642335T4/da active
- 1994-03-24 JP JP52197694A patent/JP4107678B2/ja not_active Expired - Lifetime
- 1994-03-24 NZ NZ263632A patent/NZ263632A/en not_active IP Right Cessation
- 1994-03-24 HU HU9403437A patent/HU227344B1/hu unknown
- 1994-03-24 CN CN94190160A patent/CN1104891C/zh not_active Expired - Lifetime
- 1994-03-24 PL PL94306421A patent/PL175326B1/pl unknown
- 1994-03-24 CA CA002135639A patent/CA2135639C/fr not_active Expired - Lifetime
- 1994-03-24 PT PT94912116T patent/PT642335E/pt unknown
- 1994-03-24 EP EP94912116A patent/EP0642335B2/fr not_active Expired - Lifetime
- 1994-03-24 AT AT94912116T patent/ATE189771T1/de active
- 1994-03-24 DE DE69423028T patent/DE69423028T3/de not_active Expired - Lifetime
- 1994-03-24 KR KR1019940704397A patent/KR100316206B1/ko not_active IP Right Cessation
- 1994-03-24 ES ES94912116T patent/ES2144516T5/es not_active Expired - Lifetime
- 1994-03-24 SK SK1437-94A patent/SK280362B6/sk not_active IP Right Cessation
- 1994-03-24 RU RU94046147A patent/RU2136283C1/ru active
- 1994-03-24 CZ CZ942986A patent/CZ284924B6/cs not_active IP Right Cessation
- 1994-03-24 WO PCT/SE1994/000264 patent/WO1994022431A1/fr active IP Right Grant
- 1994-03-24 AU AU64393/94A patent/AU680891C/en not_active Expired
- 1994-11-16 EE EE9400376A patent/EE03147B1/xx unknown
- 1994-11-29 NO NO944565A patent/NO310015B1/no not_active IP Right Cessation
- 1994-11-29 FI FI945621A patent/FI113743B/fi not_active IP Right Cessation
- 1994-11-30 LV LVP-94-228A patent/LV10684B/xx unknown
-
2000
- 2000-04-26 GR GR20000401009T patent/GR3033325T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3033325T3 (en) | Controlled release preparation containing a salt of morphine. | |
NZ508526A (en) | Opioid formulations for treating pain | |
YU48583B (sh) | Postupak za pripremanje formulacije u obliku pilule za oralno davanje | |
CA2098738A1 (fr) | Compositions d'oxycodone a degagement progressif | |
CA2264852A1 (fr) | Utilisation de methylphenidate ou d'un sel pharmaceutique acceptable correspondant | |
CA2105165A1 (fr) | Forme pharmaceutique pour l'administration de medicaments a liberation prolongee | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
GEP19991686B (en) | Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same | |
GEP20002229B (en) | Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same | |
AU2223095A (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
EP0866656A4 (fr) | Inhibition du facteur alpha de necrose tumorale | |
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
ES2026304A6 (es) | Procedimiento de fabricacion de una forma de dosificacion de nicardipina. | |
WO1997025049A1 (fr) | Composition contenant de la diosgenine | |
EP0409893A4 (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
HUP9900521A2 (hu) | Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására | |
GB2121277A (en) | Preparations for combating colds and flu, containing iron salt and calcium lactate | |
MY114610A (en) | Controlled drug delivery system for diltiazem. | |
MY110769A (en) | Controlled release oxycodone compositions. | |
SI0859595T1 (en) | Therapeutic preparation for the transdermal administration of active substances | |
AU5912794A (en) | Method and compositions for noninvasive dose to effect administration of lipophilic drugs | |
AU1470697A (en) | Method and compositions for noninvasive dose to effect administration of lipophilic drugs | |
RU95120783A (ru) | Способ профилактики и лечения атеросклероза |